A new study demonstrates that combining fMRI brain connectivity, cognitive reward testing, and clinical markers to guide antidepressant selection increases patient response rates by nearly 67%.
Trending
- Details On Taylor Swift & Travis Kelce’s Wedding Games & Swag
- Neuroscientists shed light on the illusion of learning from short videos
- Biomarkers Boost Antidepressant Success Rates by 67%
- Mild Cardiac Issues Trigger Long-Term Memory Loss
- Early Pregnancy Hormones Predict IQ
- Bitcoin rebounds after Trump says he’s become ‘a big crypto guy’
- Wall Street sends strong 4-word verdict on the stock market
- Best Buy issues sobering pricing warning for customers
